| Skin permeation and antinociception of compounded topical cyclobenzaprine hydrochloride formulations. E Bryson, R Hartman, J Arnold, G Gorman, S Sweitzer, S Asbill International Journal of Pharmaceutical Compounding 19 (2), 161-166, 2015 | 8 | 2015 |
| Skin permeation and antinociception of topical gabapentin formulations. E Bryson, S Asbill, S Sweitzer International Journal of Pharmaceutical Compounding 18 (6), 504-511, 2014 | 8 | 2014 |
| Safety and efficacy of 7 days on/7 days off versus 14 days on/7 days off schedules of capecitabine in patients with metastatic colorectal cancer: a retrospective review E Bryson, E Sakach, U Patel, M Watson, K Hall, A Draper, C Davis, ... Clinical Colorectal Cancer 20 (2), 153-160, 2021 | 3 | 2021 |
| Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant A Sivakumar, EB Bryson, KH Hall, KT Maples, S Goyal, NS Joseph, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (3 …, 2022 | 2 | 2022 |
| Switching to an alternative ALK-inhibitor after alectinib-induced pneumonitis resulted in resolution of this adverse event E Bryson, S Ramalingam, T Beardslee Current Problems in Cancer: Case Reports 2, 100023, 2020 | 2 | 2020 |
| Analgesic Efficacy and Penetration of Compounded Gabapentin Creams: Finding an Optimal Dose and Pre-Treatment Time EB Bryson, CS Asbill | | 2016 |
